Pericentrin expression in Down's syndrome

Area of Science:

• Genetics
• Molecular Biology
• Human Physiology

Background:

• Down syndrome (DS), characterized by trisomy 21, is the leading genetic cause of intellectual disability.
• The pericentrin gene (PCNT), located in the critical region for DS on chromosome 21q22.3, is implicated in various pathologies when altered.

Purpose of the Study:

• To investigate the differential expression of PCNT mRNA in peripheral blood leukocytes of individuals with DS compared to a normal population.
• To explore the potential involvement of PCNT gene expression changes in the molecular mechanisms of Down syndrome.

Main Methods:

• Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was employed to measure PCNT mRNA levels.
• A case-control study design was utilized, comparing DS subjects with healthy controls.

Main Results:

• PCNT gene expression was found to be significantly increased by 72.72% in 16 out of 22 DS samples.
• Elevated PCNT mRNA levels were observed in peripheral blood leukocytes of individuals with Down syndrome relative to the control group.

Conclusions:

• The study suggests that altered expression levels of the PCNT gene may be implicated in the molecular pathogenesis of Down syndrome.
• These findings highlight PCNT as a potential factor contributing to the complex mechanisms underlying DS.